Pharming (PHAR) EBIT (2020 - 2026)
Pharming (PHAR) reported EBIT of $29.90 for Q3 2026, up 89.2% from $15.80 a year earlier.
Powered by 
Analysis
Pharming (PHAR) EBIT (2020 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Pharming's EBIT came in at -$8.5 million; for FY2025, it came in at $25.84 million.
- EBIT has a five-year compound annual growth rate of -19.5% (FY2020 to FY2025).
- By year, EBIT came in at -$15.3 million in FY2024, -$5.39 million in FY2023, $28.4 million in FY2022 (+65.1%) and $17.2 million in FY2021 (-77.4%).
- The Q3 2026 figure ranks as the highest quarterly EBIT since Q2 2025.
- Year over year, EBIT gained in 1 of the last four quarters, with an average decline of 29.6%.
- The high point for year-over-year EBIT in five years was Q3 2024 (growth of 114.9%); the low point was Q3 2025 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q3 2026 came in at -$3.6 million (Q2 2026), -$4.9 million (Q1 2026) and $6.20 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Pharming | 898.85 Mn | 429.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 29.90 |
| Jun 30, 2026 | -3.60 Mn |
| Mar 31, 2026 | -4.91 Mn |
| Dec 31, 2025 | 6.20 |
| Sep 30, 2025 | 15.80 |
| Jun 30, 2025 | 3.81 Mn |
| Mar 31, 2025 | -7.04 Mn |
| Dec 31, 2024 | 6.70 |
| Sep 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | -19.43 Mn |
| Mar 31, 2024 | -16.31 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 5.30 Mn |
| Mar 31, 2023 | -13.66 Mn |
| Dec 31, 2022 | -10.20 Mn |
| Sep 30, 2022 | 7.80 Mn |
| Jun 30, 2022 | 17.80 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Dec 31, 2021 | 15.30 Mn |
API Access
Pharming EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=PHAR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "PHAR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=PHAR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();